| ARGENX SE EO -,10 |
| Niederlande |
| Gesundheit |
| NL0010832176 / A11602 |
| 1AE (Frankfurt) |
| FRA:1AE, ETR:1AE, 1AE:GR |
| EuroStoxx50 |
| https://www.argenx.com/ |
|
argenx SE is a commercial-stage biopharmaceutical ..
>Volltext.. |
| 43730.22 Mio. EUR |
| 40422.14 Mio. EUR |
| 2834.71 Mio. EUR |
| 384.4 Mio. EUR |
| 1192.53 Mio. EUR |
| 19.8 EUR |
| 37.17 Mio. EUR |
| 1796.81 Mio. EUR |
| 500.33 Mio. EUR |
| 3.77 |
| 87.66% |
| - |
| - |
| - |
| - |
| - |
| ARGENX |
| 30.10.25 |
|